166 related articles for article (PubMed ID: 10872839)
41. Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages.
Yang D; Chen Q; Le Y; Wang JM; Oppenheim JJ
J Immunol; 2001 Mar; 166(6):4092-8. PubMed ID: 11238658
[TBL] [Abstract][Full Text] [Related]
42. Discovery of Trp-Nle-Tyr-Met as a novel agonist for human formyl peptide receptor-like 1.
Wan HX; Zhou C; Zhang Y; Sun M; Wang X; Yu H; Yang X; Ye RD; Shen JK; Wang MW
Biochem Pharmacol; 2007 Jul; 74(2):317-26. PubMed ID: 17517377
[TBL] [Abstract][Full Text] [Related]
43. Receptors for chemotactic formyl peptides as pharmacological targets.
Le Y; Yang Y; Cui Y; Yazawa H; Gong W; Qiu C; Wang JM
Int Immunopharmacol; 2002 Jan; 2(1):1-13. PubMed ID: 11789660
[TBL] [Abstract][Full Text] [Related]
44. Peptides from the amino-terminus of mouse mitochondrially encoded NADH dehydrogenase subunit 1 are potent chemoattractants.
Shawar SM; Rich RR; Becker EL
Biochem Biophys Res Commun; 1995 Jun; 211(3):812-8. PubMed ID: 7598710
[TBL] [Abstract][Full Text] [Related]
45. Expression of functional formyl peptide receptors by human astrocytoma cell lines.
Le Y; Hu J; Gong W; Shen W; Li B; Dunlop NM; Halverson DO; Blair DG; Wang JM
J Neuroimmunol; 2000 Nov; 111(1-2):102-8. PubMed ID: 11063827
[TBL] [Abstract][Full Text] [Related]
46. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR.
Rabiet MJ; Huet E; Boulay F
Eur J Immunol; 2005 Aug; 35(8):2486-95. PubMed ID: 16025565
[TBL] [Abstract][Full Text] [Related]
47. Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells.
Lee HY; Kim MK; Park KS; Bae YH; Yun J; Park JI; Kwak JY; Bae YS
Biochem Biophys Res Commun; 2005 May; 330(3):989-98. PubMed ID: 15809093
[TBL] [Abstract][Full Text] [Related]
48. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes.
Kuscher K; Danelon G; Paoletti S; Stefano L; Schiraldi M; Petkovic V; Locati M; Gerber BO; Uguccioni M
Eur J Immunol; 2009 Apr; 39(4):1118-28. PubMed ID: 19291700
[TBL] [Abstract][Full Text] [Related]
49. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors.
Yoshimura K; Shibata J; Kimura T; Honda A; Maeda Y; Koito A; Murakami T; Mitsuya H; Matsushita S
AIDS; 2006 Oct; 20(16):2065-73. PubMed ID: 17053352
[TBL] [Abstract][Full Text] [Related]
50. Activation of human monocytes by a formyl peptide receptor 2-derived pepducin.
Lee HY; Kim SD; Shim JW; Kim HJ; Kwon JY; Kim JM; Baek SH; Park JS; Bae YS
FEBS Lett; 2010 Sep; 584(18):4102-8. PubMed ID: 20804753
[TBL] [Abstract][Full Text] [Related]
51. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
Morikis D; Rizos AK; Spandidos DA; Krambovitis E
Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
[TBL] [Abstract][Full Text] [Related]
52. Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity.
Lin C; Wei W; Zhang J; Liu S; Liu Y; Zheng D
Mol Cancer Ther; 2007 Oct; 6(10):2618-25. PubMed ID: 17938258
[TBL] [Abstract][Full Text] [Related]
53. Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization.
Szabo I; Wetzel MA; Zhang N; Steele AD; Kaminsky DE; Chen C; Liu-Chen LY; Bednar F; Henderson EE; Howard OM; Oppenheim JJ; Rogers TJ
J Leukoc Biol; 2003 Dec; 74(6):1074-82. PubMed ID: 12972507
[TBL] [Abstract][Full Text] [Related]
54. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
Miao Z; Premack BA; Wei Z; Wang Y; Gerard C; Showell H; Howard M; Schall TJ; Berahovich R
J Immunol; 2007 Jun; 178(11):7395-404. PubMed ID: 17513790
[TBL] [Abstract][Full Text] [Related]
55. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.
Kurosaka K; Chen Q; Yarovinsky F; Oppenheim JJ; Yang D
J Immunol; 2005 May; 174(10):6257-65. PubMed ID: 15879124
[TBL] [Abstract][Full Text] [Related]
56. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach.
Quehenberger O; Pan ZK; Prossnitz ER; Cavanagh SL; Cochrane CG; Ye RD
Biochem Biophys Res Commun; 1997 Sep; 238(2):377-81. PubMed ID: 9299516
[TBL] [Abstract][Full Text] [Related]
57. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family.
Murphy PM; Ozçelik T; Kenney RT; Tiffany HL; McDermott D; Francke U
J Biol Chem; 1992 Apr; 267(11):7637-43. PubMed ID: 1373134
[TBL] [Abstract][Full Text] [Related]
58. Lysophosphatidylglycerol inhibits formyl peptide receptorlike-1-stimulated chemotactic migration and IL-1beta production from human phagocytes.
Shim JW; Jo SH; Kim SD; Lee HY; Yun J; Bae YS
Exp Mol Med; 2009 Aug; 41(8):584-91. PubMed ID: 19381066
[TBL] [Abstract][Full Text] [Related]
59. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
[TBL] [Abstract][Full Text] [Related]
60. Differential activation of formyl peptide receptor-like 1 by peptide ligands.
Bae YS; Yi HJ; Lee HY; Jo EJ; Kim JI; Lee TG; Ye RD; Kwak JY; Ryu SH
J Immunol; 2003 Dec; 171(12):6807-13. PubMed ID: 14662886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
